<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Problems of Virology</journal-id><journal-title-group><journal-title xml:lang="en">Problems of Virology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы вирусологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0507-4088</issn><issn publication-format="electronic">2411-2097</issn><publisher><publisher-name xml:lang="en">Central Research Institute for Epidemiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">11832</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Myelopeptide 2 and the results of immunization of guinea pigs by live measles vaccine</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние миелопептида 2 на результаты иммунизации морских свинок живой коревой вакциной</trans-title></trans-title-group></title-group><pub-date date-type="pub" iso-8601-date="2004-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2004</year></pub-date><volume>49</volume><issue>2</issue><issue-title xml:lang="en">NO2 (2004)</issue-title><issue-title xml:lang="ru">№2 (2004)</issue-title><fpage>18</fpage><lpage>20</lpage><history><date date-type="received" iso-8601-date="2023-06-09"><day>09</day><month>06</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2004, Lyashenko V.A., Mikhailova A.A., Alexander S.K., Yuminova N.V., Fonina L.A., Kolyshkina V.M.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2004, Ляшенко В.А., Михайлова А.А., Александер С.К., Юминова Н.В., Фомина Л.А., Колышкин В.М.</copyright-statement><copyright-year>2004</copyright-year><copyright-holder xml:lang="en">Lyashenko V.A., Mikhailova A.A., Alexander S.K., Yuminova N.V., Fonina L.A., Kolyshkina V.M.</copyright-holder><copyright-holder xml:lang="ru">Ляшенко В.А., Михайлова А.А., Александер С.К., Юминова Н.В., Фомина Л.А., Колышкин В.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://virusjour.crie.ru/jour/article/view/11832">https://virusjour.crie.ru/jour/article/view/11832</self-uri><abstract xml:lang="en"><p>A model is suggested to study the effects the myelopeptide 2 (MP2) immunomodulator on the results of live measles rash immunized by vaccine. Guinea pigs were found to respond to live measles vaccine L-16 the way man does, i.e. the antibodies' level in their sera was increasing until days 28-56 after a single intramuscular vaccine injection. An intramuscular injection of the MP2 immunomodular, made alongside with vaccination, was demonstrated to enhance the immune response to the measles vaccine and to induce its action. Finally, it was for the first time, that the possibility was proven to enhance the action of the live measles vaccine by an immunomodulator.</p></abstract><trans-abstract xml:lang="ru"><p>Предложена модель для изучения воздействия иммуномодулятора миелопептида 2 (МП2) на результаты иммунизации живой коревой вакциной. Установлено, что морские свинки отвечают на живую коревую вакцину L-16 по "человеческому" типу: уровень антител в их сыворотках нарастает до 28-56-го дня после однократной внутримышечной инъекции вакцины. Одновременная с вакциной внутримышечная инъекция иммуномодулятора МП2 усиливает иммунный ответ на коревую вакцину и ускоряет его развитие. Впервые показана возможность усиления действия живой коревой вакцины иммуномодулятором.</p></trans-abstract><kwd-group xml:lang="en"><kwd>measles vaccine</kwd><kwd>myelopeptide 2</kwd><kwd>immunomodulator</kwd><kwd>antibodies' synthesis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>коревая вакцина</kwd><kwd>миелопептид 2</kwd><kwd>иммуномодулятор</kwd><kwd>синтез антител</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Ляшенко В. А. Коревая иммунодепрессия в условиях инфекции и вакцинации // Иммунология. - 1996. - № I. - С. 10-12.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ляшенко В. А., Лавров В. Ф., Юминова Н. В., Ковалева Л. Г. Иммунодепрессивное действие вирусов кори in vitro // Вопр. вирусол. - 1999. - № 1. - С. 39-41.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Ляшенко В. А., Александер С. К., Ковалева Л. Г. и др. // Ранние проявления иммуномодулирующего действия коревой вакцины в эксперименте in vitro // Мед. иммунол. - 2002. - Т. 4, № 1. - С. 21-27.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ляшенко В. А., Михайлова А. А., Юминова Н. В. и др. Оценка раннего иммунодепрессивного действия вируса кори и его коррекции in vitro на примере живой коревой вакцины // Биопрепараты. - 2002. - № 4. - С. 10-16.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Миелопептиды / Петров Р. В., Михайлова А. А., Фонина Л. А., Степаненко Р. Н. - М., 2000. - С. 181.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Разина Э. Э., Худавердян О. Е., Штейнберг Л. Ш. Сравнительные клинико-морфологические исследования коревой и паротитной инфекций в эксперименте на морских свинках // Вопр. вирусол. - 1988. - № 3. - С. 342-347.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Adae М. М., Komada Y., Zhang X. L. et al. Immunological unresponsiveness and apoptotic cell death of T cells in measles virus infection // Acta Paediatr. Jpn. - 1995. - Vol. 37. - P. 308-314.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Atabani S., Landucci G., Steward M. V. et al. Sex-associated differences in the antibody-dependent cellular cytotoxicity antibody response to measles vaccines // Clin. Diagn. Lab. Immunol. - 2000. - Vol. 7, N 1. - P. 111-113.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Dorig H. E., Mareil A., Chopra A. et al. The human CD46 molecule is a receptor for measles vims (Edmonston strain) // Cell. - 1993. - Vol. 75. - P. 295-305.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Griffin D. E., Ward B. J., Elosen L. M. Pathogenesis of measles virus infection: an hypothesis for altered immune response // J. Infect. Dis. - 1994. - Vol. 170. - P. 24-31.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Hussay G. D., Goddard E., Hughes J. et al. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune responses in infants // J. Infect. Dis. - 1996. - Vol. 173. - P. 1320-1326.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Mc Chesney M. В., Altmann A., Oldstone M. B. A. Suppression of T-lymphocytes function by measles virus is due to cell cycle arrest in Gl // J. Virol. - 1988. - Vol. 140. -P. 1269-1273.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Niwiesk S., Eisenhuth I., Fooks A. et al. Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins // J. Virol. - 1997. - Vol. 71. - P. 7214-7219.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Sanches-Lanier M., Guerlin P., Mc Laren M. С et al. Measlesinduced suppression of lymphocyte proliferation // Cell. Immunol. - 1988. - Vol. 116. - P. 367-381.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Schlender J., Schnorr J. J., Spielhoffer P. et al. Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induced immunosuppression in vitro // Proc. Natl. Acad. Sci. USA. - 1996. - Vol. 93. P. 13194-13199.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Schneider-Schaulies S., Bieback K., Avota E. et al. Regulation of gene expression in lymphocytes and antigen-presenting cells by measles virus: consequences for immunomodulation // J. Mol. Med. - 2002. - Vol. 80. - P. 73-85.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Schnorr J. J., Seufert M., Schlender J. et al. Cell cycle arrest rather than apoptosis associated with measles virus contact-mediated measles virus immunosuppression in vitro // J. Gen. Virol. - 1997. - Vol. 78. - P. 3217-3226.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Seng R., Samb В., Simondon F. et al. Increased long term mortality associated with rash after early measles vaccination in rural Senegal // Pediatr. Infect. Dis. J. - 1999. - Vol. 18, N 1. - P. 48-52.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Shinji Ohgimoto, Kaori Ohgimoto, Stefan Niewiesk et al. The haemaglutinin protein is an important determinant of measles virus tropism for dendritic cells in vitro // J. Gen. Virol. - 2001. - Vol. 82. - P. 1835-1844.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Whittle H., Aaby P., Samb B. et al. Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines // Pediatr. Infect. Dis. J. - 1999. - Vol. 18, N 1. - P. 53-57.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Wong T. C., Yant S., Harder B. J. et al. The cytoplasmic domains of complement regulatory protein CD46 interact with multiple kinases in macrophages // J. Leucocyte Biol. - 1997. - Vol. 62, N 6. - P. 892-900.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Yanagi Y., Cubitt В., Oldstone M. B. Measles virus inhibits mitogen-induced T-cell proliferation but does not directly perturb the T-cell activation process inside the cell // Virology. - 1992. - Vol. 187. - P. 280-289.</mixed-citation></ref></ref-list></back></article>
